Reeflex Solutions Inc. Provides Bi-Weekly Status Update on MCTO
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, AB / ACCESS Newswire / January 14, 2026 / Reeflex Solutions Inc. (TSXV:RFX) ("Reeflex" or the "Company") ais providing this bi-weekly status update in …
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
CALGARY, AB / ACCESS Newswire / January 14, 2026 / Reeflex Solutions Inc. (TSXV:RFX) ("Reeflex" or the "Company") ais providing this bi-weekly status update in accordance with National Policy 12-203 Management Cease Trade Orders ("NP 12-203").
As previously announced on December 31, 2025, the Company applied for and was granted a management cease trade order ("MCTO") by the Alberta Securities Commission (the "ASC"), as principal regulator of the Company, due to a delay in the filing of its audited annual financial statements, management's discussion and analysis and related CEO and CFO certifications (the "Certificates") for the financial year ended August 31, 2025 (collectively, the "Annual Filings") by the required deadline of December 29, 2025.
The MCTO restricts the Company's CEO and CFO from trading in the Company's securities until the Annual Filings are made but will not affect the ability of the general investing public to trade in the Company's common shares.
As disclosed in the Company's initial default announcement, the Company underwent a complex transaction, transitioning from a private, family-owned business to a fully IFRS-compliant public company by way of a reverse takeover transaction on May 16, 2025, and related acquisition of Coil Solutions Inc. ("CSI") on May 15, 2025 (together, the "Transaction"). The Company changed its year end from December 31, 2025 to August 31, 2025 to align with the year end of its operating subsidiary, CSI. The Company also appointed MNP LLP as its new auditor, who advised that the Company's interim financial statements for the quarter ended May 31, 2025, accompanying MD&A and Certificates (the "Q3 Filings") are required to be restated to reflect CSI's results only from the May 15, 2025 acquisition date, in accordance with IFRS. The need to restate the Q3 Filings, together with first-time public company audit requirements, has extended the time required to complete the audit of the Company's year-end results and the preparation of the Annual Filings.
While the Company previously announced that it expected to complete the Annual Filings and restatement of the Q3 Filings on or about January 29, 2026, due to the complexity of the audit requirements, and certain additional staffing constraints, the Company now expects that it may require additional time to complete these filings. The preparation of the Company's interim financial statements for the quarter ended November 30, 2025, accompanying MD&A and Certificates (the "Q1 Filings"), which are due to be filed by January 29, 2026, are also expected to be delayed. The Company has requested, but not yet received, the approval of the ASC to complete the Annual Filings, the Q1 Filings and the restatement of the Q3 Filings on or before February 19, 2026.

